— Know what they know.
Not Investment Advice

NURO NASDAQ

NeuroMetrix, Inc.
1W: +0.0% 1M: +5.8% 3M: +4.8% 1Y: +4.1% 3Y: -83.0% 5Y: -74.6%
$4.58
Last traded 2025-05-09 — delisted
NASDAQ · Healthcare · Medical - Devices · $9.4M mcap · 2M float · 0.349% daily turnover · Short 17% of daily vol

Cash Flow Trends

Operating Cash Flow
-$7M -17.1% ▼
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$7M -13.7% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$304K +88.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$2M-$2M-$4M-$7M-$8M
Depreciation & Amort.$90K$76K$49K$56K$233K
Stock-Based Comp.$599K$698K$477K$700K$729K
Change in Working Capital-$1M-$1M-$2M$126K$570K
Other Non-Cash Items$44K$666K$313K-$437K-$855K
Operating Cash Flow-$2M-$2M-$5M-$6M-$7M
— Investing Activities —
Capital Expenditures$0-$132K-$23K-$184K$0
Acquisitions (Net)$0$0-$24M$0$0
Investment Purchases$0$0-$41M-$30M-$41M
Investment Sales$0$0$24M$31M$46M
Other Investing$0$0$24M$0$0
Investing Cash Flow$0-$132K-$17M$1M$5M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$0$0
Financing Cash Flow$4M$20M$4M$2M$1M
Net Change in Cash$2M$17M-$18M-$3M-$304K
Cash End of Period$5M$23M$4M$2M$1M
Free Cash Flow-$2M-$2M-$5M-$6M-$7M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms